The Manufacturers Life Insurance Company cut its stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 76.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,936 shares of the company's stock after selling 29,240 shares during the period. The Manufacturers Life Insurance Company's holdings in Azenta were worth $447,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently modified their holdings of the company. Picton Mahoney Asset Management grew its position in shares of Azenta by 305.7% during the 4th quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock worth $35,000 after buying an additional 532 shares during the period. Headlands Technologies LLC acquired a new stake in Azenta during the 4th quarter worth $40,000. Covestor Ltd grew its holdings in Azenta by 64.2% during the 4th quarter. Covestor Ltd now owns 2,043 shares of the company's stock worth $102,000 after acquiring an additional 799 shares during the period. KBC Group NV raised its position in shares of Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after acquiring an additional 698 shares during the last quarter. Finally, Quarry LP acquired a new position in shares of Azenta in the 4th quarter valued at $110,000. 99.08% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of research firms recently commented on AZTA. Evercore ISI upped their price objective on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. TD Cowen upgraded Azenta to a "hold" rating in a research report on Thursday, February 27th. Finally, Needham & Company LLC cut their price target on shares of Azenta from $59.00 to $40.00 and set a "buy" rating on the stock in a research report on Wednesday, May 7th.
Read Our Latest Analysis on AZTA
Azenta Trading Up 2.8%
Shares of Azenta stock opened at $27.47 on Friday. The stock's fifty day simple moving average is $30.00 and its 200 day simple moving average is $41.54. The company has a market capitalization of $1.26 billion, a PE ratio of -9.22 and a beta of 1.64. Azenta, Inc. has a 12 month low of $23.91 and a 12 month high of $63.58.
Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. During the same period in the prior year, the company earned $0.06 earnings per share. The firm's quarterly revenue was up 5.1% compared to the same quarter last year. Analysts predict that Azenta, Inc. will post 0.53 EPS for the current fiscal year.
Azenta Profile
(
Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Recommended Stories
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.